







- Stock: In Stock
- Model: 178951
0% Customers recommend this product
-
5 Awesome0%
-
4 Great0%
-
3 Average0%
-
2 Bad0%
-
1 Poor0%
Reviews Over Tsiprofarm cap. eye. / ush. 0.3% fl. 10 ml
- (0)
Total Reviews (0)
click here write review to add review for this product.
Report this review.
Description
Pharmacological properties
Pharmacodynamics. antimicrobial broad-spectrum agent of group of ftorkhinolon. possesses bactericidal action which mechanism is caused by oppression of a dnk-giraza of bacteria with violation of synthesis of DNA, growth and cell fission.
Possesses a wide range of antimicrobial action with the greatest activity concerning gram-negative bacteria and less expressed influence on anaerobe bacterias. Highly active concerning the majority of gram-negative bacteria: Pseudomonas aeruginosa, Haemophilus influenzae, Escherichia coli, Shigella spp., Salmonella spp., Neisseria meningitidis, N. gonorrhoeae. It is active concerning many strains of Staphylococcus spp. (producing or not producing penicillinase, metitsillinrezistentny), some strains of Enterococcus spp. and also Campylobacter spp., Legionella spp., Mycoplasma spp., Chlamidia spp., Mycobacterium spp. Ciprofloxacin is active concerning the bacteria producing β-lactamelements.
Pharmacokinetics. At topical administration of medicine the therapeutic concentration of active ingredient is reached in fabrics and biological liquids of an eye or tissues of an ear.
Indication
Helcoma and superficial infections of an eye (eyes) and its appendages, caused by the strains of bacteria sensitive to ciprofloxacin.
Acute otitis of an external ear and also sharp otitis of a middle ear with drenazhy through a timpanostomichesky tube, caused by strains of the bacteria sensitive to ciprofloxacin.
Use
Use in ophthalmology
Use for adults, including patients of advanced age
Helcoma: Tsiprofarm should be applied within a day with such intervals, including night time:
1st day: to dig in 2 drops in a sore eye each 15 min. during the first 6 h, then on 2 drops each 30 min. within the first day.
2nd day: to dig in 2 drops in a sore eye each hour
to dig inC of the 3rd in 14th put on 2 drops in a sore eye each 4 h. If it is necessary to continue treatment more than 14 days, the scheme of dosing is defined by the doctor.
In a helcoma the treatment can last more than 14 days, the scheme of dosing and duration of treatment are defined by the doctor.
Bacterial superficial infections of an eye and its appendages. The standard dose makes 1–2 drops in a conjunctival sac of each affected eye 4 times a day. In heavy infections the dose can make 1–2 drops each 2 h in the first 2 days in the afternoon. Usually treatment continues 7–14 days.
toAfter instillation recommends dense closing a century or lacrimonasal occlusion. It reduces system absorption of the medicine entered into an eye that reduces the probability of system side effects.
in case of the accompanying therapy by other local ophthalmologic medicines needs to observe an interval 10–15 min. between their application.
Children. The same dosing, as well as for adults.
For treatment of bacterial conjunctivitis at children 1 years Tsiprofarm are aged more senior thanapply 1–2 drops 3–4 times a day for 4 days.
to prevent pollution of a tip of a bottle and solution, it is necessary to be careful and not to touch centuries, adjacent sites or other surfaces a bottle tip.
Use in otology
Adult, including people of advanced age. The dose makes 4 drops of medicine Tsiprofarm in acoustical pass 2 times a day. For adult patients who need application of earplugs the dose can be doubled only at the first application (that is 8 drops).
generally duration of treatment should not exceed5–10 days. In certain cases treatment can be prolonged, but then it is necessary to check sensitivity of local microflora.
in case of the accompanying therapy by other local medicines needs to observe an interval between their receptions 10–15 min.
Children. Safety and efficiency of ciprofloxacin, a thaw of eye/ear 3 mg/ml, at application in otology is established only for children aged 1 years are more senior. The medicine dose Tsiprofarm makes 3 drops in acoustical pass 2 times a day. For children who need use of earplugs the dose can be doubled only at the first application (that is 6 drops).
to prevent pollution of a tip of a bottle and solution, it is necessary to be careful and not to touch an auricle or acoustical pass, adjacent parts of the body or other surfaces a bottle tip.
needs to clean external acoustical pass carefully. To prevent vestibular stimulation, it is recommended to enter solution of room temperature or body temperature. The patient has to lie on an opposite side of rather sore ear. It is desirable to be in such situation within 5–10 min. Also after local clarification it is possible to enter the moistened tampon from a gauze into acoustical pass or from hygroscopic cotton wool for 1–2 days, but it needs to be moistened for saturation with medicine 2 times a day.
Contraindication
Hypersensitivity to hinolona or to auxiliary ingredients of solution. viral and fungus diseases of an eye (eyes).
Side effects
Disturbance from an organ of sight: often — sensation of discomfort, a white plaque (it was observed at patients with a helcoma and at frequent use of medicine. the plaque appeared, as a rule, during the period of 24 h up to 7 days after an initiation of treatment and disappeared or at once, or for 13 days after the beginning of therapy), feeling of a foreign body, formation of scales / kristallikov, hyperaemia of a conjunctiva and an itch; in isolated cases — coloring of a cornea, a keratopathy/keratitis, allergic reactions, the century, dacryagogue, a photophobia, infiltration of a cornea and decrease in visual acuity swelled.
Disturbance from an organ of hearing: often — an itch in an ear; in isolated cases — a ring in an ear.
Disturbance from skin: dermatitis.
Others: unpleasant smack in a mouth, nausea, a headache.
Special instructions
Should stop use of medicine tsiprofarm at emergence of the first symptoms of rash on skin or other signs of hypersensitivity reaction.
toIt was reported about serious, and sometimes and lethal cases of reaction of hypersensitivity (anaphylactic reactions) at patients who applied hinolona systemically, and at some patients after the first dose. Some reactions were followed by cardiovascular collapse, a loss of consciousness, pricking, hypostasis of a throat or face, dispnoe, urticaria and an itch. Heavy anaphylactic reactions demand urgent treatment using epinephrine and other resuscitation actions, including oxygen therapy, in/in injections, in/in introduction of antihistaminic medicines, GKS, the amines narrowing vessels, IVL according to clinical indications.
byrevealed phototoxic action from average to heavy degree in the form of heavy sunblisters at patients who were affected by direct sunshine during system use of medicines of a class of hinolon. It is necessary to avoid excessive impact of sunlight. In case of phototoxicity the treatment needs to be stopped.
Prolonged use of ciprofloxacin, as well as any other antibacterial medicines, can lead to activization of growth of microorganisms, insensitive to it, including mushrooms.
should carry out byAt emergence of superinfection the corresponding treatment.
Eye/ear drops Tsiprofarm contain a benzalkoniya chloride as preservative which can cause irritation. It is also known that this preservative can decolour soft contact lenses therefore before use of medicine Tsiprofarm patients have to remove contact lenses and wait 15 min. after medicine instillation Tsiprofarm before again putting on contact lenses.
According to the standard rule, use of contact lenses in the presence of an infection of eyes is undesirable.
At use of medicine Tsiprofarm for treatment of otitis is recommended to perform medical examination of patients for timely establishment of need of application of other therapeutic actions (system application of antibiotics, surgical treatment).
Ability to influence speed of response at control of vehicles or work with other mechanisms. As well as in case of application of other eye drops, the temporary illegibility of sight or other disorders of vision can affect ability to steer vehicles or work with other mechanisms. If the illegibility of sight takes place, the patient needs to wait until the sight is restored before steering vehicles or other mechanisms.
toAfter use of medicine Tsiprofarm in an ear it was not reported about any effects affecting ability to steer vehicles or to work with other mechanisms.
Use during pregnancy or feeding by a breast. As controlled researches with participation of pregnant women were not conducted, Tsiprofarm should be applied during pregnancy only when the expected advantage for mother prevails over potential risk for a fruit.
do not havedata on whether ciprofloxacin gets into breast milk after topical administration. Therefore the women nursing should be careful at appointment of Tsiprofarm.
Children. The efficiency and safety at use of medicine aged till 1 year are not established to children.
Drug is used for treatment of children aged 1 years are more senior.
data that simultaneous use of some system quinolines leads to increase in concentration of theophylline in blood plasma, influences metabolism of caffeine and strengthens effect of oral anticoagulants, such as warfarin and its derivatives Are p>
Interaction.
In blood plasma at patients who accepted cyclosporine together with system ciprofloxacin the creatinine level temporarily increased. Tsiprofarm is incompatible with alkaline solutions (bases).
Incompatibility. Tsiprofarm is incompatible with alkaline solutions (bases).
Overdose
in case of medicine overdose tsiprofarm at topical administration in an eye should wash up surplus of medicine from an eye (eyes) warm water.
in case of overdose of medicine at topical administration in an ear the patient has to lay down, turn sideways and wait until the surplus of liquid follows from an ear.
Storage conditions
B the place protected from light at a temperature of 8-25 °C. not to freeze. an expiration date after opening of a bottle — 28 days
Specifications
Characteristics | |
Active ingredients | Ciprofloxacin |
Amount of active ingredient | 3 mg/ml |
Applicant | Pharmak |
Code of automatic telephone exchange | S03AA07 Ciprofloxacin |
Interaction with food | It doesn't matter |
Light sensitivity | Sensitive |
Market status | The branded generic |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | bottle |
Producer | PUBLIC JOINT STOCK COMPANY PHARMAK |
Quantity in packing | 10 ml |
Release form | eye and ear drops |
Route of administration | Ear and Eye |
Sign | Domestic |
Storage temperature | from 5 °C to 25 °C |
Trade name | Tsiprofarm |